A detailed history of Humankind Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Humankind Investments LLC holds 4,976 shares of AMGN stock, worth $1.47 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
4,976
Previous 4,847 2.66%
Holding current value
$1.47 Million
Previous $1.51 Million 5.88%
% of portfolio
0.59%
Previous 0.41%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $39,910 - $43,522
129 Added 2.66%
4,976 $1.6 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $205,733 - $250,019
783 Added 19.27%
4,847 $1.51 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $9,948 - $12,008
37 Added 0.92%
4,064 $1.16 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $19,944 - $22,499
-78 Reduced 1.9%
4,027 $1.16 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $162,019 - $201,151
-741 Reduced 15.29%
4,105 $1.1 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $9,213 - $10,894
-43 Reduced 0.88%
4,846 $1.08 Million
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $181,986 - $221,811
806 Added 19.74%
4,889 $1.18 Million
Q4 2022

Jan 26, 2023

SELL
$229.03 - $291.01 $128,943 - $163,838
-563 Reduced 12.12%
4,083 $0
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $162,509 - $183,280
724 Added 18.46%
4,646 $1.05 Million
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $203,947 - $226,958
-884 Reduced 18.39%
3,922 $954,000
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $40,784 - $45,118
-186 Reduced 3.73%
4,806 $1.16 Million
Q4 2021

Mar 21, 2022

BUY
$198.88 - $227.6 $174,815 - $200,060
879 Added 21.37%
4,992 $1.12 Million
Q3 2021

Mar 21, 2022

BUY
$212.27 - $248.7 $249,841 - $292,719
1,177 Added 40.09%
4,113 $875,000
Q2 2021

Mar 21, 2022

BUY
$233.58 - $259.14 $252,967 - $280,648
1,083 Added 58.45%
2,936 $716,000
Q1 2021

Mar 21, 2022

BUY
$221.91 - $258.6 $411,199 - $479,185
1,853 New
1,853 $461,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.